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Background: The long-term patency of arteriovenous fistulas (AVFs) and arteriovenous grafts (AVGs) suffers from a high
incidence of primary failure due to early thrombosis, myointimal hyperplasia at the venous access site, or failure tomature.
A multidisciplinary meeting in vascular access surgery was initiated to optimize the timing, indication, type of
intervention, and the logistics of AVFs/AVGs during the preoperative and postoperative period. This study evaluated the
influence of the new optimized care protocol on the incidence of revisions (surgical and endovascular) and patency rates.
Methods: This protocol for vascular access surgery of AVFs/AVGs for hemodialysis was introduced in January 2004. It
was initiated with the presence of the vascular surgeons, nephrologists, interventional radiologists, dialysis nurses, and
the ultrasound technicians. Every patient who needed an AVF/AVG because of long-term treatment of chronic renal
failure or awaiting kidney transplantation, or who needed a revision of an AVF/AVG, was discussed. Two groups were
compared. Group I patients were treated with an AVF/AVG before the introduction of the new protocol (2001 and
2002). Group II patients were treated with an AVF/AVG after the introduction of the new optimized care protocol
(2004 and 2005). Both groups were followed up after 12 months.
Results: During the study period, 146 AVFs/AVGs were attempted, and 111 postoperative revisions were performed to
restore primary and secondary patency: 63 in group I (60 surgical, 3 radiology) and 48 in group II (23 surgical, 25
radiology). Significantly more segmental access replacements (P < 0.027) occurred in group I than in group II.
Significantly fewer surgical revisions (P < 0.019) and more endovascular balloon angioplasties (P < 0.001) occurred in
group II. Significantly higher cumulative primary and secondary patency rates of all AVFs/AVGs (P < 0.001),
radial-cephalic direct wrist AVFs (P < 0.001), and brachial-cephalic forearm looped transposition AVGs (P < 0.001)
were achieved in group II after follow-up.
Conclusion: The new protocol outlined in a bimonthly multidisciplinary meeting for vascular access surgery of AVFs/
AVGs for hemodialysis resulted in more effective logistics according to preoperative diagnostics and operation. More
importantly, a significant increase in endovascular balloon angioplasties and a significant decrease in surgical revisions was
observed, resulting in less patient morbidity. Also, higher primary and secondary patency was achieved after the
introduction of the new optimized care protocol. ( J Vasc Surg 2008;48:659-68.)Arteriovenous fistulas (AVFs) and arteriovenous grafts
(AVGs) are the methods of long-term hemodialysis access
for patients with from end-stage renal disease (ESRD). The
ideal AVFs/AVGs should be durable, pose minimal risk for
infection, and require few revisions to maintain ongoing
functional patency. However, AVFs and AVGs have a high
incidence of primary failure due to early thrombosis, my-
ointimal hyperplasia, or failure to mature. Vascular access
complications substantially contribute to morbidity and
hospitalization in hemodialysis patients. Estimates of pri-
mary failure, primary patency, and secondary patency vary
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doi:10.1016/j.jvs.2008.04.002considerably. Early thrombosis and failure to mature are
significant problems, occurring in 20% to 50% of AVFs.1
The prospective identification of patients who are
prone to early AVF/AVG failure is of high clinical impor-
tance. These patients may especially benefit from a multi-
disciplinary approach in which all factors contributing to
access graft failure are assessed. Moreover, a standardized
preoperative diagnostic work-up, specific treatment guide-
lines considering graft type and location, and predeter-
mined postoperative follow-up with a standardized surveil-
lance protocol could be of value in optimizing access graft
patency and thereby reduce patient morbidity.
In 1997 the National Kidney Foundation Disease Out-
come Quality Initiative (NKF-DOQI) Work Group and
European Guidelines for Vascular Access represented a
comprehensive consensus statement using evidence-based
methods to provide guidelines to optimize care of patients
with ESRD.2-4 TheNational Vascular Access Improvement
Initiative (NVAII) statement recommends a multidisci-
plinary implementation of protocol-driven surveillance
programs for early detection and treatment of failing vas-
cular access conduits.5 Several studies have evaluated indi-
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prehensive follow-up programs to enhance maturation or
standard preoperative work-up with duplex ultrasound
(DUS) examination.6-17
The implementation of a standardized protocol with
emphasis on preoperative work-up and postoperative sur-
veillance embedded in a bimonthly multidisciplinary meet-
ing on access graft surveillance has been rarely reported. In
the present study we evaluate the effectiveness of a prede-
termined optimized care protocol (OCP) monitored in a
bimonthly multidisciplinary meeting for vascular access
surgery of AVFs and AVGs for hemodialysis, which was
introduced in January 2004. The objective of the present
study was (1) to evaluate the incidence of surgical and
endovascular revisions and (2) to compare the primary and
secondary patency rates between the historical control
group and the group treated using the OCP.
METHODS
Patient demographics. Patient characteristics and
Table I. Patient demographics, comorbidity risk factors, a
Characteristicsa Total
Patients, No. 146
Sex
Male 82 (56)
Female 64 (44)
Age, years
55 26 (18)
55-69 38 (26)
70-79 59 (40)
80 23 (16)
ASA class21
2 69 (47)
3 75 (51)
4 2 (1)
Comorbidity
Cardiac disease 73 (50)
Pulmonary disease 30 (21)
Carotid disease 25 (17)
Diabetes mellitus 32 (22)
Hypertension 109 (75)
Hyperlipidemia 53 (36)
Dilatating arterial disease 13 (9)
Occlusive arterial disease 24 (16)
SVS-ISCVS risk, score (SD)18-20 1.27
Primary renal disease
Diabetic nephropathy 14 (10)
Hypertension nephropathy 11 (8)
Glomerulonephritis 20 (14)
Polycystic renal disease 16 (11)
Nephrosclerosis 36 (25)
Medication 10 (7)
Obstructive nephropathy 6 (4)
Collagen vascular disease 6 (4)
Miscellaneous/unknown 27 (18)
ASA, American society of Anesthesiologists; SD, standard deviation; SVS-ISC
of Cardiovascular surgery.
aData are presented as number (%), unless otherwise specified.
bAdmissions were because of treatment with a primary arteriovenous fistula or
cAdmissions were because of treatment with a primary arteriovenous fistula ormedical history (cardiac disease, pulmonary disease, cere-bral disease, diabetes mellitus, hypertension, hyperlipid-
emia and age) were collected prospectively during the
admission intake, classified according to the Society of
Vascular Surgery/North American Chapter, International
Society of Cardiovascular Surgery (SVS/ISCVS) stan-
dards,18-20 and graded in severity. The American Society of
Anesthesiologists (ASA) classification21 of patients was de-
termined according to their general condition. The primary
causes of ESRD (diabetic, hypertension; medications such
as analgesics, cyclosporine, or lithium; obstructive nephropa-
thy and collagen vascular diseases) were registered and are
listed with the other patient characteristics in Table I.
Study period and follow-up. A retrospective obser-
vational clinical review was conducted of data for patients
referred for permanent hemodialysis access to the vascular
surgery practice in a single major dialysis center, at the
Haga Hospital of The Hague, the Netherlands. Results of
dialysis access procedures were compared between two
periods: January 2001 to December 2002 (follow-up until
December 2003: maximum 1 year) vs January 2004 to
rimary renal disease
Group Ib Group IIc P
72 74
.095
35 (49) 47 (64)
37 (51) 27 (36)
.008
13 (18) 13 (18)
15 (21) 23 (31)
38 (53) 21 (28)
6 (8) 17 (23)
.189
31 (43) 38 (51)
41 (57) 34 (46)
0 (0) 2 (3)
40 (56) 33 (45) .246
11 (15) 19 (26) .152
16 (22) 9 (12) .127
13 (18) 19 (26) .319
55 (76) 54 (73) .705
22 (31) 31 (42) .172
6 (8) 7 (9) .811
11 (15) 13 (18) .824
1.34 (0.44) 1.22 (0.41) .08
.173
6 (8) 8 (11)
5 (7) 6 (8)
10 (14) 10 (14)
8 (11) 8 (11)
18 (25) 18 (24)
7 (10) 3 (4)
1 (1) 5 (7)
6 (8) 0 (0)
11 (15) 16 (22)
ociety of Vascular Surgery/North American Chapter, International Society
the year 2001 and 2002, with follow-up from 2001 to 2003 (mean, 1 year).
the year 2004 and 2005, with follow-up from 2004 to 2006 (mean, 1 year).nd p
VS, SDecember 2005 (follow-up until December 2006: maxi-
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were after institution of a new OCP (January 2004) out-
lined in a multidisciplinary meeting held every other week
for planning therapy for these patients.
Since then, all patients with indication of vascular access
surgery (primary surgery or a revision) were evaluated
according to this protocol and assessed in this meeting to
optimize patient outcome. Important to stress is that the
same number of patients was dependent on dialysis at the
time of access placement during both periods. AVFs/AVGs
performed in 2003 were excluded because during this year
the new protocol was not in practice; therefore, this year
was used as independent follow-up year of the AVFs/AVGs
performed in January 2001 to December 2002.
The Optimized Care Protocol. Every patient who
was to receive an AVF/AVG because of long-term treat-
ment of chronic renal failure or awaiting kidney transplan-
tation, or who was to receive a revision of an AVF/AVG,
was evaluated according to our new protocol outlined in a
bimonthly multidisciplinary meeting of vascular access sur-
gery of AVFs/AVGs for hemodialysis. In this meeting the
vascular surgeons, nephrologists, interventional radiolo-
gists, the ultrasound technicians and dialysis nurses partic-
ipated and assessed the medical records and dialysis charts
of these patients in a structured standardized manner using
a prefixed individual patient work sheet. The purpose of
this protocol was (1) to optimize and standardize preoper-
ative work-up with emphasis on access site selection, (2) to
optimize postoperative surveillance to detect and treat po-
tential access graft failure early, and (3) to optimize com-
munication among all specialist involved in the treatment
of vascular access graft patients.
Preoperative workup. The preoperative standardized
workup included careful assessment of the vascular anat-
omy. Arterial examination included pulse assessment, per-
formance of the Allen test, and bilateral upper extremity
blood pressure measurement. Venous examination in-
cluded inspection and palpation of the cephalic vein at the
wrist and upper arm and the basilica vein at the elbow, with
a tourniquet in place.
Both arms were evaluated with DUS by an experienced
sonographer. The diameter of the radial artery at the wrist
and the brachial artery immediately above the antecubital
fossa were determined. Veins were assessed on the ade-
quacy of the superficial vein, on ease of compressibility,
thickness, continuity, and depth below the skin. The eval-
uation of stenosis or occlusion of the deep venous system
(axillary and subclavian veins) was registered. The mini-
mum acceptable threshold for internal diameters for arter-
ies and veins were set at 2.0 mm according to the NKF-
DOQI guidelines,2-4 the Vascular Access Society,22,23 and
overall hemodialysis literature.6,7,24
Measurements of vein diameter were recorded at rep-
resentative sites, including wrist, distal forearm, middle
forearm, proximal forearm, antecubital fossa, distal upper
arm, middle upper arm, and proximal upper arm. In case of
a suspected inflow stenosis or occlusion, contrast angiogra-
phy was used to optimize preoperative work-up. Venogra-phy was performed selectively if no suitable vein was iden-
tified at DUS. There was more thorough preoperative
evaluation concerning standardized DUS and angioplasty.
The protocol we used for access site and type is autog-
enous before prosthetic and distal arm before proximal to
conserve sites. If technically possible, the nondominant
extremity was used for construction of the AVF/AVG;
however, the final decision was ultimately determined ac-
cording to the size and quality of the vessels on the basis of
results of clinical examination and DUS examination.
Important to be mentioned about the later period is
that there was no timelier referral. Patients were not re-
ferred earlier for hemodialysis access in their disease course,
and the waiting time from referral to operation was the
same.
Arteriovenous hemodialysis access surgery. The
AVF procedures were autogenous radial-cephalic direct
wrist access, brachial-cephalic direct access, and brachial-
basilic transpositions. An end-to-side anastomosis was
made with a running 6-0 or 7-0 monofilament suture
between the vein and artery. The AVG procedures were
brachial-cephalic looped transpositions with polytetrafluo-
roethylene (PTFE) grafts. Also ProCol shunts (Hancock
Jaffe Laboratories, Irvine, Calif) were used. All operations
were performed by or under the supervision of a vascular
surgeon, and there was no change in surgeons or quality of
surgeons during the study period.
A surgical revision of a failed AVF/AVG could be a
thrombectomy, a segmental access replacement, a surgical
percutaneous transluminal angioplasty (PTA), or a correc-
tion of a postoperative hemorrhage or aneurysm. A PTA
could also be an endovascular revision performed by the
interventional radiologist. Percutaneous thrombectomy,
stenting, or placement of stent grafts were not part of the
protocol; however all thrombectomies were performed sur-
gically. All operations were performed under local, re-
gional, or general anesthesia. AVFs were allowed at least 6
weeks to develop before puncture for hemodialysis. An
AVF was considered to have matured when the diameter of
the vein was sufficient to provide adequate dialysis.
Data of the surgical interventions are listed in Tables II
and III. Because the same experienced vascular surgeons
operated in both periods, the quality of surgeons and
executed operations did not change during this study pe-
riod. The same holds for the interventional radiologists and
the quality of their expertise. Also no differences existed in
type of referral patterns, operation room facilities, and
reimbursement patterns.
Postoperative surveillance. As listed in Fig 1, a more
intensive use of surveillance occurred in the newOCP study
period. The first postoperative visit was at the dialysis center
for examination, suture removal, and patient education
after 1 week. The patient underwent a directed physical
examination for signs of impending thrombosis or lack of
maturation during regular visits at the dialysis center 3
times a week. The problems that would initiate an urgent
assessment were: (1) high venous pressures (250 mmHg
at a 400 mL/min pump speed), (2) difficult cannulation,
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flow rate 600 mL/min, (4) minimal thrill with low flow
suspected, (5) minimal increase in vein dilatation, (6) in-
creasing arm edema, (7) barely audible or highly pitched
bruit, or (8) physical signs of suspected stenosis after careful
palpation of the entire length of the AVF/AVG.
When AVF/AVG failure was suspected, DUS imaging
was performed to evaluate stenosis before occlusion, and
the AVF/AVG was automatically evaluated according to
the OCP and earlier reintroduced at the multidisciplinary
meeting for a possible surgical or endovascular revision.
The DUS results were not validated by fistulography in all
cases as specified by the protocol. Criteria for a hemody-
namically significant stenosis (50% reduction in luminal
diameter) were based on guidelines of previously published
reports.13,24,25 If stenosis in case of maturation failure,
conduit stenosis, and native arterial stenosis was detected in
the region of the venous anastomosis or anywhere along
the draining vein or the central veins, PTA was the treat-
ment of choice. It was performed with a 5- to 8-mm-
diameter balloon catheter.
Definitions of patency and success of the AVF/AVG.
Definitions of patency were those recommended by the
Committee on Reporting Standards for Arteriovenous Ac-
cess of the SVS and the American Association for Vascular
Surgery.17-19 Technical success was defined as the presence
of a thrill on palpation or bruit on auscultation 24 hours
postoperatively. The primary patency and secondary pa-
tency rates (including initial failure to mature in 6 weeks)
were determined at regular intervals: 1, 3, 6, 9, and 12
months. Primary patency was described as the interval from
the time of access placement until the first intervention
designed to maintain or re-establish patency, access throm-
bosis, or the time of measurement of patency. Secondary
patency was described as the interval from the time of access
placement until access abandonment, thrombosis, or the
time of patencymeasurement including interveningmanip-
Table II. Total revisions of 111 arteriovenous fistulas in g
Procedures a Total
Total revisions 111 (0,0,9)
Surgical revisionsd
Thrombectomy 36 (0,0,4)
Segmental access replacement 18 (0,0,4)
Balloon angioplasty 25 (0,0,4)
Bleeding 1 (0,0,1)
Aneurysm 3 (0,0,2)
Total 83 (0,0,9)
Endovascular revisionse
Balloon angioplasty 28 (0,0,5)
aData are presented as number (median, minimum, maximum), unless othe
bAdmissions were because of treatment with a primary arteriovenous fis
(mean, 1 year).
cAdmissions were because of treatment with a primary arteriovenous fistul
1 year).
dRevisions were done by a surgeon.
eRevisions were done by an interventional radiologist.ulations (surgical or endovascular interventions) designedto re-establish functionality in thrombosed access. Inade-
quate maturation was defined as insufficient access flow to
maintain dialysis or the unavailability to cannulate an AVF,
if required, at 6 weeks after surgery. AVFs that never
matured were included in the patency rates.
Registration and statistical analysis. By using Access
software (Microsoft Inc, Redmond, Wash), patient infor-
I and group II
Group Ib Group IIc P
63 (0,0,9) 48 (0,0,6) .894
25 (0,0,4) 11 (0,0,3) .087
15 (0,0,4) 3 (0,0,2) .026
16 (0,0,4) 9 (0,0,3) .261
1 (0,0,1) 0 (0,0,0) .311
3 (0,0,2) 0 (0,0,0) .151
60 (0,0,9) 23 (0,0,6) .019
3 (0,0,2) 25 (0,0,5) .001
specified.
r graft in the year 2001 and 2002, with follow-up from 2001 to 2003
aft in the year 2004 and 2005, with follow-up from 2004 to 2006 (mean,
Table III. Summary of arteriovenous access procedures
in groups I and II
Arteriovenous access surgery a Total Group Ib Group IIc P
Patients, total 146 72 74
Hemodialysis access .063
AVF
Brachial-cephalic upper
arm direct access 2 (1) 0 (0) 2 (3)
Brachial-basilic upper arm
transposition 6 (4) 0 (0) 6 (8)
Radial-cephalic direct
wrist accessd 83 (57) 41 (57) 42 (57)
AVG
Brachial-cephalic looped
transposition 53 (36) 30 (42) 23 (31)
ProCol shunte 2 (1) 1 (1) 1 (1)
Material used .409
PTFE 53 (36) 30 (42) 23 (31)
ProCol 2 (1) 1 (1) 1 (1)
Autogenous 91 (62) 41 (57) 50 (68)
AVF, Arteriovenous fistula; AVG, arteriovenous graft; PTFE,
polytetrafluoroethylene.
aData are presented as number (%), unless otherwise specified.
bAdmissions were because of treatment with a primary arteriovenous fistula
or graft in the year 2001 and 2002, with follow-up from 2001 to 2003
(mean, 1 year).
cAdmissions were because of treatment with a primary arteriovenous fistula
or graft in the year 2004 and 2005, with follow-up from 2004 to 2006
(mean, 1 year).
dBrescia-Cimino fistula.
eHancock Jaffe Laboratories, Irvine, California.roup
rwise
tula o
a or grmation was entered on a specifically designed computerized
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yses were performed using Excel (Microsoft) and SPSS
12.01 software (SPSS Inc, Chicago, Ill). Follow-up was
complete in all patients (mean, 12 months). The Fisher
exact test, Student t test, or 2 test were used to assess
differences between both groups for a given variable. The
postoperative revisions were analyzed with the Mann-
Whitney U test. The Kaplan-Meier survival method was
used to calculate the time curve of the cumulative primary
and secondary patency at 1, 3, 6, 9, and 12 months after
AVF/AVG creation. The log-rank test was used for com-
Fig 1. Flow chart shows protocol for treatment, multi
venous hemodialysis access with arteriovenous fistulas (
transluminal angioplasty.parison of the primary and secondary patency rates. For allstatistical analyses, a value of P  .05 was considered to be
statistically significant.
RESULTS
Patient demographic, AVFs, and AVGs. The hemo-
dialysis population at the Haga Hospital at any time totals
approximately 80 patients. During the two study periods,
146 primary access procedures—91 primary AVFs (62%)
and 55 AVGs (38%)—were performed in 82 men (56%)
and 54 women (44%) as well as 111 additional revisions.
Fifty-six of all AVFs (62%) were created in women. There
linary meeting, and follow-up of patients with arterio-
) and arteriovenous grafts (AVG). PTA, percutaneousdiscip
AVFwere no significant differences with regard to ASA classifi-
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these patients (56%) were aged 70 years. In the study
group (group II), patients were significantly more likely to
be 80 years. Table I summarizes demographics, comor-
bidity, and primary renal disease. No patients were lost to
follow-up.
Group I: historical control group. Patients in group
I had 72 access procedures (49%), 41 AVFs (57%) and 31
AVGs (43%), performed between January 2001 and De-
cember 2002, with follow-up until 2003. Twenty-one of all
AVFs (51%) were created in women. Three radiologic
PTAs (5%) and 60 surgical revisions (95%) were done to
maintain function in 46 AVFs/AVGs (64%). This resulted
in an 88% rate for total revision. Twenty-six AVFs/AVGs
(36%) never underwent a revision by a surgeon or an
interventional radiologist.
The cumulative primary patency rates by Kaplan-Meier
analysis of all AVFs/AVGs at 1, 3, 6, 9, and 12 months
were 69%, 50%, 40%, 36%, and 36%, respectively. The
cumulative secondary patency rates of all AVFs/AVGs were
76%, 61%, 54%, 53%, and 47%, respectively. The summary
of the AVFs/AVGs, postoperative revisions, cumulative
primary and secondary patency results are listed in Tables
Table IV. Cumulative life-table primary and secondary pa
grafts in group Ia and IIb
Patency c 1 month 3 month
All AVFs and AVGs
Primary patency
All 146 (79) 116 (62
Group I 72 (69) 50 (50
Group II 74 (89) 66 (74
Secondary patency
All 146 (84) 123 (72
Group I 72 (76) 55 (61
Group II 74 (92) 68 (82
AVFd
Primary patency
All 83 (74) 61 (57
Group I 41 (63) 26 (44
Group II 42 (83) 35 (69
Secondary patency
All 83 (76) 63 (59
Group I 41 (66) 27 (46
Group II 42 (86) 36 (72
AVGe
Primary patency
All 53 (87) 46 (68
Group I 30 (80) 24 (60
Group II 23 (96) 22 (78
Secondary patency
All 53 (94) 50 (87
Group I 30 (90) 27 (80
Group II 23 (100) 23 (96
AVF, Arteriovenous fistula; AVG, arteriovenous graft.
aGroup I admissions were because of treatment with a primary arteriovenous fistul
bGroup II admissions were because of treatment with a primary arteriovenous fistu
cData are presented as number (%), unless otherwise specified.
dRadial-cephalic direct wrist access, Brescia-Cimino fistula.
eBrachial-cephalic forearm looped transposition.II, III, and IV and outlined in Figs 2, 3, and 4.Group II: study group. The study group patients
underwent 74 access procedures (51%), consisting of 50
AVFs (68%) and 24 AVGs (32%), performed between
January 2004 and December 2005, with follow-up until
2006. Thirty-five of all AVFs (70%) were created in women.
A total of 23 surgical revisions (48%) and 25 radiologic
PTAs (52%) were done to maintain function in 38 AVFs/
AVGs (50%), for a total revision rate of 63%. Thirty-eight
AVFs/AVGs (50%) never underwent a revision by a sur-
geon or an intervention radiologist.
The cumulative primary patency rates, obtained by
Kaplan-Meier analysis, of all AVFs/AVGs at 1, 3, 6, 9,
and 12 months were 89%, 74%, 61%, 54%, and 49%,
respectively. The cumulative secondary patency rates of
all AVFs/AVGs were 92%, 82%, 77%, 74%, and 70%,
respectively. The summary of the AVFs/AVGs, postop-
erative revisions, cumulative primary and secondary pa-
tency results are listed in Tables II, III, and IV and
outlined in Figs 2, 3, and 4.
Group comparison. No significantly differences
were found between the two groups regarding the sort of
AVFs/AVGs (P  .063) and material used in AVFs/
AVGs (P  .409), as listed in Table III. For surgical
y rates of 83 arteriovenous fistulas and 53 arteriovenous
6 months 9 months 12 months
91 (51) 74 (45) 66 (42)
36 (40) 29 (36) 26 (36)
55 (61) 45 (54) 40 (49)
105 (66) 96 (64) 93 (59)
44 (54) 39 (53) 38 (47)
61 (77) 57 (74) 55 (70)
47 (45) 37 (41) 34 (37)
18 (34) 14 (32) 13 (32)
29 (55) 23 (50) 21 (43)
49 (51) 42 (49) 41 (46)
19 (37) 15 (37) 15 (37)
30 (64) 27 (62) 26 (55)
36 (59) 31 (49) 26 (49)
18 (50) 15 (43) 13 (43)
18 (70) 16 (57) 13 (57)
46 (85) 45 (81) 43 (74)
24 (77) 23 (73) 22 (60)
22 (96) 22 (91) 21 (91)
ft in the year 2001 and 2002, with follow-up from 2001 to 2003 (mean, 1 year).
aft in the year 2004 and 2005, with follow-up from 2004 to 2006 (mean, 1 year).tenc
s
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
a or gra
la or grrevisions, there was a statistically significant difference in
ar). P
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group II. This resulted in a decrease of the total of
surgical revisions (P  .019) and an increase of endovas-
cular PTAs performed by the interventional radiologist
(P  .001). A significant difference was achieved be-
tween group I and group II in primary patency rates of all
AVFs/AVGs (36% vs 49%; P .001), the radial-cephalic
direct wrist access AVFs (32% vs 43%, P  .001), and the
brachial-cephalic looped transposition AVGs (43% vs
57%, P  .001) after 1 year of follow-up. A significant
difference between group I and group II was achieved in
secondary patency rates for the respective AVFs/AVGs
(47% vs 70%, P  .001), the radial-cephalic direct wrist
access AVFs (37% vs 55%, P  0.001) and the brachial-
cephalic looped transposition AVGs (60% vs 91%, P 
0.001) after 1 year of follow-up, as listed in Tables II,
III, and IV and outlined in Figs 2, 3 , and 4 .
DISCUSSION
Arteriovenous hemodialysis access surgery is complex.
The multidisciplinary nature, preoperative workup of
the patient, timing of the operation, selection of the
vascular access site, surgical technique, postoperative
monitoring, and early detection of AVF/AVG failure are
all important aspects to ensure an uninterrupted hemo-
dialysis access and a good long-term survival. In this
study, the effect of a newly introduced protocol outlined
in a regular bimonthly multidisciplinary meeting on the
long-term patency of AVFs/AVGs was assessed. After
the initiation of this protocol in January 2004, all pa-
tients with an indication of vascular access placement or
with undercurrent complications or access problems
were discussed according to a new protocol outlined in
this meeting attended by the vascular surgeons, neph-
rologists, interventional radiologists, the ultrasound
technicians, and dialysis nurses.
To achieve the best outcome for every individual
0
10
20
30
40
50
60
70
80
90
100
p<0.087p<0.019
thrombectomy 
p<0.894
total
revisions 
total
surgical
revisions 
%
Fig 2. Summary of revisions in 63 group I patients (
admissions because of treatment with a primary arteriove
2001 and 2002, with follow-up from 2001 to 2003 (m
2005, with follow-up from 2004 until 2006 (mean, 1 yepatient, the team agreed on a set of goals, to collaborateclosely, and maintain good communication. The medical
records and dialysis charts registered in a standardized
manner were discussed and policy was made. This pro-
tocol ensured that every patient was analyzed in the most
optimal way with the best interpretation of medical
history, physical examination, and additional diagnostic
imaging.
In this study, the overall primary and secondary 1-year
patency rates improved from 36% to 49% and from 47% to
70%, respectively. The primary and secondary 1-year pa-
tency rates of the radial-cephalic direct wrist access (AVF)
improved from 32% to 43% and from 37% to 55%, respec-
tively. Furthermore, the primary and secondary 1-year pa-
tency rates of the brachial-cephalic forearm looped trans-
position (AVG) improved from 43% to 57% and from 60%
to 91%, respectively. When primary and secondary 1-year
patency rates were compared for all AVFs/AVGs, and
AVFs and AVGs between the two groups, a significant
difference in favor of group II was seen. The patency rates
are quite reasonable, meet NKF-DOQI guidelines,2-4 and
are in accordance with and sometimes compare favorably
with the results of others.26-33
The results of this study indicate that evaluating
individual patients with vascular access indications or
postoperative vascular access complications according to
a new strict OCP in a regular bimonthly multidisciplinary
meeting with all specialists surrounding the vascular
access patient improves vascular access patency signifi-
cantly. Although the total of all revisions, surgical and
endovascular, did not differ significantly, a significant
decrease of all of surgical revisions and an increase of all
PTAs was achieved after the implementation of this new
OCP embedded in the bimonthly multidisciplinary
meeting.
The greater use of PTA may reflect changes in practice
and the identification of AVF/AVG stenosis before throm-
bosis through better monitoring of access function in the
group I
group II
.026 p<0.261 p<0.001
ental  
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      surgical 
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   endovascular 
   PTA 
and 48 group II (43%) patients. Group I comprised
fistulas (AVF) or arteriovenous grafts (AVG) in the year
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ean, 1dialysis center. These changes in revisions reduce morbid-
JOURNAL OF VASCULAR SURGERY
September 2008666 Flu et ality, shorten the hospitalization period, and decrease the
cost of hemodialysis treatment for the individual patient
and health care in general. This is a cohort study without
significant differences between both groups with regard to
risk factors of AVF/AVG failure.
The improved outcome of vascular access function after
the initiation of the OCP outlined in the biweekly multi-
disciplinary meeting in January 2004 is presumably caused
by several factors:
First, a consistent analysis of the medical history and
physical examination of every single patient in a strict
manner using a prefixed individual patient data sheet
during the plenary multidisciplinary meeting ensured
that no vital information was lost and that potential
causes of future vascular access graft failure, such as
central venous thrombosis, were assessed meticu-
lously. If arterial inflow or venous outflow reduction
was suspected, additional imaging studies were con-
ducted, ultimately striving for a complete preopera-
tive workup.
Second, a careful selection of access site in patients for an
AVF or AVG is of the utmost importance. In the
period after January 2004, strict minimal diameters
Fig 3. Kaplan-Meier curves for cumulative secondary patency
(SP) rates of 83 radial-cephalic direct wrist access (Brescia-Cimino
fistula) arteriovenous fistulas (AVF) or grafts (AVG) in group I
(n  41) and group II (n  42). Data are presented as number at
risk (%), unless otherwise specified. Admissions were because of
treatment with a primary AVF/AVG in the year 2001 and 2002 for
group I, with follow-up from 2001 to 2003 (mean, 1 year), and in
the year 2004 and 2005 for group II, with follow-up from 2004 to
2006 (mean, 1 year).of arterial inflow and venous outflow segments, reg-istered by DUS imaging in every patient preopera-
tively, were implemented, as discussed previously.
Furthermore, potential venous stenosis more down-
stream in the venous outflow segment was consid-
ered an absolute contraindication for AVF placement
distally.
Third, the communis opinion among the participants of
the meeting was to create an arteriovenous fistula
whenever possible according to the protocol de-
scribed here and in Fig 1. This is in line with litera-
ture in which autogenous cephalic vein remains the
superior conduit compared with a prosthetic graft.32
The Vascular Access Work Group of the NKF-DOQI
concluded that the proportion of primary AVFs con-
structed in all new patients diagnosed with ESRD
entering hemodialysis should be at least 40%.2-4 Vein
mapping resulted in an addition of upper arm basilic
vein transposition and a slightly higher forearm AVF
rate. This resulted in our dialysis unit in an increased
prevalence of patients undergoing hemodialysis with
an AVF during the two observational periods from
57% to 68%, surpassing the guideline mandated by
the NKF-DOQI and equal to the results of study by
Allon et al.34
Fourth, the NKF-DOQI guidelines also indicate that
Fig 4. Kaplan-Meier curves for cumulative secondary patency
(SP) rates of 53 brachial-cephalic forearm looped transposition
arteriovenous grafts in group I (n  30) and group II (n  23).
Data are presented as number at risk (%), unless otherwise specified.
Admissions were because of treatment with a primary arteriovenous
graft or fistula in the year 2001 and 2002 for group I, with follow-up
from2001 to 2003 (mean, 1 year); and in the year 2004 and 2005 for
group II, with follow-up from 2004 to 2006 (mean, 1 year).outcomes for hemodialysis patients could be signifi-
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fore access thrombosis. Consistent follow-up of he-
modialysis patients with vascular access sites is the
best way to diagnose problems early. The patient
underwent directed physical examination for signs of
impending thrombosis or lack of maturation during
regular visits at the dialysis center three times a week,
which allows the best chance of rescuing an AVF or
AVG rather than creating a new one. The rescue
approach reduces morbidity and decreases the cost of
hemodialysis treatment. In our opinion, assessing
individual patients according to this OCP outlined in
a bimonthly multidisciplinary meeting with detailed
analysis of decreased dialysis flow dynamics in a strict
manner is paramount to detect and treat vascular
access stenosis. In this way, the incidence of acute
thromboses can be reduced, ultimately resulting in
increased access patencies.
CONCLUSIONS
In this study we demonstrated significant increased
primary and secondary AVF/AVG patency rates after the
initiation of a new OCP. Discussing patients on a regular
basis in a strict manner according to a predetermined
protocol resulted in significant increased endovascular re-
visions and significant decreased surgical revisions. There-
fore, this optimized care protocol outlined in a multidisci-
plinary meeting with all specialists surrounding the vascular
access patient reduces patient morbidity and is of value in
order to strive for the highest possible quality of care.
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